{Reference Type}: Case Reports
{Title}: Identification of a novel CTCF mutation responsible for syndromic intellectual disability - a case report.
{Author}: Bastaki F;Nair P;Mohamed M;Malik EM;Helmi M;Al-Ali MT;Hamzeh AR;
{Journal}: BMC Med Genet
{Volume}: 18
{Issue}: 1
{Year}: 06 2017 15
{Factor}: 2.023
{DOI}: 10.1186/s12881-017-0429-0
{Abstract}: Autosomal dominant mental retardation 21 (MRD21) is a very rare condition, characterized by short stature, microcephaly, mild facial dysmorphisms and intellectual disability that ranged from mild to severe. MRD21 is caused by mutations in CCCTC-binding factor (CTCF) and this was established through only four unrelated cases, two of which had frameshift mutations. CTCF is a master transcriptional regulator that controls chromatin structure and may serve as insulator and transcriptional activator and repressor.
This study presents, clinically and molecularly, an Emirati patient with de novo frameshift mutation in CTCF. This novel mutation was uncovered using whole exome sequencing and was confirmed by Sanger sequencing in the trio. In silico analysis, using SIFT Indel, indicates that this frameshift; p.Lys206Profs*13 is functionally damaging with the likely involvement of nonsense-mediated mRNA decay.
Upon comparing the clinical picture of the herewith-reported individual with previously reported cases of MRD21, there seems to be many common symptoms, and few new ones that were not observed before. This helps to further define this rare condition and its molecular underpinnings.